ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
ANK1 | Ankyrin 1, erythrocytic | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
C15orf27 | Chromosome 15 open reading frame 27 | Predicted membrane proteins
| | | | | Tissue enhanced |
C1orf170 | Chromosome 1 open reading frame 170 | | | | | | Tissue enhanced |
C1QTNF9 | C1q and tumor necrosis factor related protein 9 | Predicted secreted proteins
| | | | | Tissue enhanced |
CA14 | Carbonic anhydrase XIV | Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | Cancer-related genes
| | | | | Tissue enhanced |
CECR2 | Cat eye syndrome chromosome region, candidate 2 | | | | | | Tissue enhanced |
CNKSR1 | Connector enhancer of kinase suppressor of Ras 1 | Cancer-related genes
| | | | | Tissue enhanced |
CRYAB | Crystallin, alpha B | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
EN1 | Engrailed homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
EYA4 | Eyes absent homolog 4 (Drosophila) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
FAM47E-STBD1 | FAM47E-STBD1 readthrough | Plasma proteins
| | | | | Tissue enhanced |
FLNC | Filamin C, gamma | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Tissue enhanced |
FNDC5 | Fibronectin type III domain containing 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
GPD1 | Glycerol-3-phosphate dehydrogenase 1 (soluble) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
HOXC10 | Homeobox C10 | Transcription factors
| | | | | Tissue enhanced |
HSPB2-C11orf52 | HSPB2-C11orf52 readthrough (NMD candidate) | | | | | | Tissue enhanced |
HSPB6 | Heat shock protein, alpha-crystallin-related, B6 | | | | | | Tissue enhanced |
KCNQ5 | Potassium voltage-gated channel, KQT-like subfamily, member 5 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
LINC00346 | Long intergenic non-protein coding RNA 346 | | | | | | Tissue enhanced |
LMCD1 | LIM and cysteine-rich domains 1 | | | | | | Tissue enhanced |
MYF5 | Myogenic factor 5 | Transcription factors
| | | | | Tissue enhanced |
MYH8 | Myosin, heavy chain 8, skeletal muscle, perinatal | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
NANOS1 | Nanos homolog 1 (Drosophila) | Disease related genes
| | | | | Tissue enhanced |
P2RX6 | Purinergic receptor P2X, ligand-gated ion channel, 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
PACSIN3 | Protein kinase C and casein kinase substrate in neurons 3 | Plasma proteins
| | | | | Tissue enhanced |
PADI2 | Peptidyl arginine deiminase, type II | Enzymes
| | | | | Tissue enhanced |
PDLIM3 | PDZ and LIM domain 3 | Plasma proteins
| | | | | Tissue enhanced |
PHKA1 | Phosphorylase kinase, alpha 1 (muscle) | Disease related genes
| | | | | Tissue enhanced |
PITX2 | Paired-like homeodomain 2 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
PPP1R1A | Protein phosphatase 1, regulatory (inhibitor) subunit 1A | | | | | | Tissue enhanced |
PPP2R3A | Protein phosphatase 2, regulatory subunit B'', alpha | | | | | | Tissue enhanced |
SH2B2 | SH2B adaptor protein 2 | | | | | | Tissue enhanced |
SIX2 | SIX homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
SLC2A4 | Solute carrier family 2 (facilitated glucose transporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
STRIP2 | Striatin interacting protein 2 | | | | | | Tissue enhanced |
SYNM | Synemin, intermediate filament protein | | | | | | Tissue enhanced |
SYNPO | Synaptopodin | | | | | | Tissue enhanced |
SYNPO2 | Synaptopodin 2 | | | | | | Tissue enhanced |
TCEA3 | Transcription elongation factor A (SII), 3 | | | | | | Tissue enhanced |
TCF15 | Transcription factor 15 (basic helix-loop-helix) | Transcription factors
| | | | | Tissue enhanced |
TEAD4 | TEA domain family member 4 | Transcription factors
| | | | | Tissue enhanced |
USP2 | Ubiquitin specific peptidase 2 | Enzymes
| | | | | Tissue enhanced |